Skip to main content
Equibles

VISION FINANCIAL MARKETS LLC

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 1378145 STAMFORD, CT
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$144,648
-$1,142,964 QoQ
Shares Held
9,800
-96.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#144
of 192 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VISION FINANCIAL MARKETS LLC holds $182,940 across 7 Biotechnology names. SLS ranks #1 (79.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SLS
SELLAS Life Sciences Group, Inc.
This page 		9,800 $144,648
2 ADMA
Adma Biologics, Inc.
 2,975 $24,900
3 MRNA
Moderna, Inc.
 100 $7,003
4 TWST
Twist Bioscience Corp
 50 $5,144
5 CRSP
CRISPR Therapeutics AG
 20 $1,090
6 CRBP
Corbus Pharmaceuticals Holdings, Inc.
 14 $131
7 MTNB
Matinas BioPharma Holdings, Inc.
 40 $24

All Filings in SLS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $144,648 9,800
2026-03-31 $1,287,612 304,400